The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
This ****** comic artwork is so desperate to buy in its untrue.
Pathetic attempt like all negative posters to create a negative sentiment on ground breaking news.
Lot of noise coming from a lot of derampers.
Maybe self isolation is getting to them.
BP do you expect anyone to believe that you hold a single share here?
Go on jog on seen you do this countless times, pathetic mind games.
Doesn't wash.
Structured guess it could be this lot.
https://eu.idtdna.com/pages/products/gmp-oem-and-integrations/oem-services
Sometime after midnight UK time.
This ******* is making a dick of himself on Twitter. He’s going to have a go here now.
Other EUAs will come through thick and fast now.
Lol. Keep trying.
Anyone who thinks this is opening at £1.30/£1.40 is I am afraid seriously deluded.
Sorry fellas, sharpen the pencil and look for something much closer to £2, that's if you are lucky.
This will a prime takeover target now. Think they will have to pay at least £4 though for a cheeky one now.
The global distribution network and ability to manufacture testing equipment on the scale and quality they can do is a great USP
This must be the safest place for cash on the European markets at present.
Cashed up from warrants.
3.5m test kits raw material to produce into £20m+ sales.
OEMs in Europe and USA
£2.3m sales over a very small period.
That’s just from one product.
Wider business all performing well and above expectations.
Got the impression they can’t give a sales target due to the levels simply being unknown.
We will see £3 here in the short term.
Yup no warrants. Cashed up. Big order book. Global focus.
Its a market makers worst nightmare
Watch the opinion of most of these desperate ones change when they have bought a few tomorrow morning. FOMO eeks out of every post they make
Warrants held this back.
They are all gone now.
The sky is the limit.
Yuri anything in development or being developed in a university situation would likely not be available commercially in 2020 or in any quantities by mid 2021.
You know this but agenda is driving your posting.
More than a few countries in the world who need this Yuri.
Get yourself an Atlas and check out how big a placeit is.
From The Maldives to Bhuthan to Argentina they will need testing kits and tests by the millions.
Wait till the WHO announce the Pandemic word next week and the emergency funding kicks in.
The market for Novacyt will be firm for months I am afraid to say
How many times do we think someone testing positive would be re-tested before the all clear?
The Abel guy in Japan said his last test came back positive still whilst his wife is now disease free.
Perhaps he may have been tested a dozen times by now.
Number of positive cases unfortunately means several repeat tests per individual.
Likewise China now needs to keep testing ultra high to maintain the success they have had in control.
When this goes and lets hope for humanity sake it does and quick the need of this product doesn’t just end.
50 companies don’t make the Primerdesign Test. Only one that’s Novacyt and it’s the market leading one moron. Hence the difference to the other 49.......
Only global listed company to hold EU CE & China FDA
What’s not too like. Enjoy the Sunday lunch Midas. Going to be a painful week decamping this.
Given the OEM partner and the fact we can count £3m sales from the last RNS over a short period for this product alone I expect that overall sales for 2020 (calendar year) could be well in excess of £100m.
I think QIagen had sales of $1.35bn. Say we get 10% of those sales in 2020.
So that kind of makes 10% of the deal paid by Thermo for Qaingen a possible
That’s €900m.
Over £10 per share
Just to be market comparable
They are Market Leaders now. The largest Chinese specialist Coronavirus testing company doesn’t have Chinese FDA. This is so obvious to all now that double figures is a reality